Céline Gounder, KFF Health News’ editor-at-large for public health, explained on “CBS Mornings” why many at-risk Americans do not know about medication to prevent HIV infection through sexual contact or do not have access to it.
Only one-third of people who could benefit from the medication, known as preexposure prophylaxis or PrEP, are prescribed it, according to the Centers for Disease Control and Prevention.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.
